New antibiotic compound very exciting, expert says
A new antibiotic compound could help treat a bacterium the World Health Organization classes as a major threat.
Similar Posts
16 Products Under $25 That Are Shockingly Effective
As much as we love a good splurge every now and then, there’s nothing like getting your hands on a quality item that didn’t cost a fortune. But we all know that sometimes, a suspiciously affordable price tag can be a deterrent. What if the item doesn’t work, is cheap and breaks after just one…
Climate Change and Corporate Responsibility: How Businesses Can Lead the Charge
In the tapestry of modern challenges, climate change stands as a colossus, casting a long shadow over our collective future. Yet, within this challenge lies an unprecedented opportunity for the corporate world to spearhead a revolution, not just in how businesses operate, but in how they can galvanize global efforts towards sustainability. As the clarion…
What are nitazenes? What to know about the drug that can be 10 times as potent as fentanyl
Colorado law enforcement warning about opioid recently showing up in overdose toxicology reports Colorado law enforcement warning about opioid recently showing up in overdose toxicology reports 01:13 An overdose death in Colorado has been linked to a new formulation of nitazenes, a class of powerful opioid analgesics being increasingly seen in the illicit drug market….
Healthcare software vendor NextGen explores sale | Reuters News Agency
Business & FinanceDealsHealth 23 August 2023, 2:10 pm 1 minute Reuters exclusively reported that NextGen Healthcare (NXGN.O), a provider of software that helps manage patients’ records, is exploring options that include a sale of the company. Market Impact NextGen shares rose 10% to $18.01 on the news in afternoon trading in New York on Wednesday,…
Edwards Lifesciences cooperating with EU antitrust regulators | Reuters News Agency
Health 27 September 2023, 2:03 pm 1 minute Reuters exclusively reported that US medical device maker Edwards Lifesciences, a global leader in its field, was the target of an EU antitrust raid a week ago on concerns that it may have abuse its market power. Shares in Edwards Lifesciences shed 2.5% in pre-market trade on…
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot. The company’s stock…
